Clinical Research Directory
Browse clinical research sites, groups, and studies.
Genetic Predisposition Testing Program for Pancreatic Neuroendocrine Neoplasms
Sponsor: University of California, San Francisco
Summary
This is a prospective observational multi-center pilot study of germline testing for participants receiving care at University of California participating locations with a new or existing diagnosis of Pancreatic Neuroendocrine Neoplasms (PanNEN). This protocol is an extension of existing Genetic Testing Station efforts at University of California, San Francisco (UCSF)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
300
Start Date
2023-04-07
Completion Date
2026-12-31
Last Updated
2026-01-26
Healthy Volunteers
Not specified
Conditions
Interventions
Hereditary Cancer Panel
UCSF's Internal Clinical Laboratory Improvement Amendments of 1988 (CLIA)-certified Expanded Hereditary Cancer Panel will be employed which measures a minimum 88 genes
Locations (3)
University of California, Los Angeles
Los Angeles, California, United States
Univeristy of California, San Diego
San Diego, California, United States
University of California, San Francisco
San Francisco, California, United States